single institution. We studied the characteristics of recurrence according to pathological and clinical features and elaborated risk groups. The type and the total numbers of imaging studies performed during surveillance or until recurrence were evaluated. Outcomes of surveillance were analyzed.
INTRODUCTION AND OBJECTIVES: The accurate risk assessment of pathologic T3a renal cell carcinoma (RCC) remains a challenge. To develop a more precise risk stratification system, we investigated the prognostic impact of tumor growing into fatty tissue around kidney or renal vein.
METHODS: We retrospectively reviewed the medical records of 211 patients with a pathologic diagnosis of T3aN0M0 RCC. Recurrence free survival was estimated using the Kaplan-Meier method. Factors associated with survival outcome were studied using multivariable Cox regression analysis.
RESULTS: Overall 59% of patients had isolated fat invasion, 19% had isolated renal vein involvement, and 23% had both histologic features. Patients were divided in 2 groups: fat invasion or renal vein involvement (group A) and fat invasion plus renal vein involvement (group B). Group B had a significantly worse recurrence free survival than group A on Kaplan-Meier curve (p ¼ 0.001). At multivariable Cox regression analysis, this new stratified group B was found to be an independent prognostic predictor of recurrence free survival (HR ¼ 1.964, 95% CI ¼ 1.059-3.632, p ¼ 0.032) after adjusting for gender, tumor size, tumor necrosis, angoilymphatic invasion, and sarcomatoid differentiation.
CONCLUSIONS: Patients with pathologic T3a RCC with both fat invasion and renal vein involvement increased risk of recurrence after nephrectomy. According to fat invasion and renal vein involvement, the pathologic T3a RCC should be sub-divided into those with favorable and unfavorable disease. , sodium, and C-reactive protein [CRP]), prior nephrectomy, immunotherapy, and metastatic sites (lung, liver, and bone) were used for IG sub-stratification. Overall survival (OS) was defined as the duration from the initial MTT. Modified and original models were compared using concordance correlation coefficient analysis.
Source of
RESULTS: Median follow-up after the initial MTT was 17.8 months. According to the original criteria, total cohort were classified into FG (n¼41 [19.2%], median OS¼58.5 months), IG (n¼109 [51.2%], median OS¼33.5 months), and PG (n¼63 [29.6%], median OS¼17.1 months), respectively. Among IG cohort, multivariate analysis revealed that ALB <4 g/dL (hazard ratio [HR] ¼2.65), CRP !0.3 mg/dL (HR¼2.86), and bone metastases (HR¼2.73) were independent predictors of OS, although the remaining factors were not. IG was substratified as fIG, pIG, and iIG, according to the number of predictors present: 0, 3, or other, respectively. Thus, the modified IMDC model was developed: FG&fIG (n¼62 [29.1%], median OS¼58.5 months) vs iIG (n¼70 [32.9%], median OS¼34.9 months) vs PG&pIG (n¼81 [38.0%]; median OS¼14.8 months). The concordance indices for the original and modified models were 0.68 and 0.73, respectively (p<0.001).
CONCLUSIONS: We successfully developed a modified IMDC model using a two-step process: original IMDC plus IG sub-stratification. Our preliminary data showed that PG&pIG group treated with mTORIs in second-line setting had significantly longer OS than with TKIs, based on modified model but not original model. In addition, we are seeking molecular markers for FG&fIG, iIG, and PG&pIG in the modified model, which may contribute to select of MTT as well as newly immunotherapy agents.
Source of Funding: none

MP67-12
patterns in renal cell carcinoma (RCC) in patients with end stage renal disease (ESRD), such as acquired cystic disease (ACD)-associated and clear cell papillary RCC. In this study, a central pathologist reanalyzed the pathological findings of RCC in patients with ESRD from multiple institutions, based on the new classification.
METHODS: This study included 315 patients who underwent radical nephrectomy in 3 Japanese institutes from 1987 to 2015. A central pathologist reviewed sections from all patients according to the 2016 WHO classification.
RESULTS: Based on the new classification, clear cell was diagnosed in 144 patients (46%), ACD-associated in 100 (31%), papillary in 41 (13%), chromophobe in 10 (3%), clear cell papillary in 3 (1%), MiT family translocation in 2 (1%), and unclassified in 15 (5%). We next compared clinicopathological findings of ACD-associated RCC with those of non-ACD-associated RCC. Multivariate analysis showed that independent prognostic clinical factors for occurrence of ACDassociated RCC were the presence of acquired cystic disease of the kidney (ACDK) (hazard ratio [HR]: 2ÂD710 9 , p<0.01), age (HR: 0.97, p¼0.03), and duration of dialysis (HR: 1.06, p<0.01). We further compared pathological features in ACD-associated and other RCCs. ACD-associated included more Furman grade 3/4 (90 vs. 47%, p<0.01). In contrast, other unfavorable findings was less frequent in ACD-associated RCC, including the presence of sarcomatoid features (2 vs. 7%, p¼0.04), lymphovascular invasion (3 vs. 11%, p<0.01), and necrosis (7 vs. 13%, p¼0.18).
CONCLUSIONS: ACD-associated RCC accounts for 31% of RCC in patients with ESRD, and prognostic clinical factors for occurrence include young age, long dialysis duration, and presence of ACDK. In addition, ACD-associated RCC showed higher Furman grade, but fewer cases with other unfavorable pathological features, suggesting the need for an independent nuclear grading system for ACD-associated RCC.
Source of Funding: None
MP67-13 PURE HOST-RELATED RISK FACTORS FOR ADHERENT PERINEPHRIC FAT IN HEALTHY INDIVIDUALS DURING LAPAROSCOPIC RENAL SURGERY
Shintaro Narita*, Takamitsu Inoue, Mitsuru Saito, Taketoshi Nara, Koichiro Takayama, Kazuyuki Numakura, Hiroshi Tsuruta, Atsushi Maeno, Shigeru Satoh, Tomonori Habuchi, Akita, Akita, Japan INTRODUCTION AND OBJECTIVES: Adherent perinephric fat (APF) is a risk factor for surgical difficulty during partial nephrectomy.
No previous report has analyzed pure host-related risk factors of APF among individuals without cancer. Here, we assessed risk factors and characteristics of APF in healthy individuals.
METHODS: Men who underwent laparoscopic donor nephrectomy between 2009 and 2014 were included in the present study. Based on retrospective review of video-recorded surgical procedures during anterior perinephric fat dissection, the severity of APF was categorized into the following three groups: non-APF (0), APF (1), and severe APF (2). The relationship between APF severity and clinical/ radiographic features was evaluated. The relationship between cytokine expression in perinephric fat tissue (PAT)-conditioned medium and APF severity was also assessed using SearchLight Multiplex assays. RESULTS: Of the 92 patients, 43 (46.7%) and 8 (8.7%) were categorized as having APF and severe APF, respectively. Mean operative duration was significantly associated with APF severity (trend, P ¼ 0.00248), and patients with severe APF had a significantly higher estimated blood loss than those without (P ¼ 0.002). No difference in postoperative serum creatinine levels or rates of delayed graft function in recipients was observed among the three groups. Gender, body mass index, perinephric fat area, stranding, and thickness were significantly associated with severe APF. On multivariate analysis, perinephric fat area (OR, 1.189; P ¼ 0.005) and the presence of renal stranding (OR, 14.450; P ¼ 0.037) were identified as independent risk factors for severe APF. Of the 44 analyzed cytokines, mean levels of sIL-6R in PAT-conditioned medium were found to be significantly higher in the APF groups than in the non-APF group (P ¼ 0.049). In a validation study with a larger number of donors (n ¼ 48), mean sIL-6R levels remained significantly higher in both groups with APF compared to the non-APF group (P ¼ 0.042).
CONCLUSIONS: Several radiographic features, such as perinephric fat area and stranding, were found to be pure host-related risk factors for severe APF. sIL-6R secreted from adipose tissues may have utility in predicting the severity of APF in patients undergoing renal surgery. Pure host-related risk factors for APF may predict difficulty during perinephric fat dissection. (RCC) . The association between RCC and other subtypes of STSs has not been studied; thus, we aim to assess this relationship and report our experience on patients with RCC and GISTs.
Source of
METHODS: We retrospectively reviewed our institutional database to identify patients with pathologically confirmed STSs and cooccurring RCC between January 1980 and June 2016. Clinical and pathologic characteristics of patients with RCC and STS subtypes were collected. Chi square analysis and Fisher's exact test were used to compare RCC in GIST to other STSs. RESULTS: We identified 5371 patients with STSs and 402 with GISTs. Mean follow-up time was 11.4 [3.6-23.6] years. RCC had a statistically significant (p¼0.009) higher co-occurrence in GIST (n¼6, 1.6%) compared to other STSs (n¼20, 0.40%). The GIST cohort compared with the other STS cohort had a higher proportion of metachronous occurrence (66.7% vs. 40%). In addition, when analyzing the e876 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
